Status:
COMPLETED
Celecoxib in Postoperative Analgesia for Radius Fracture Surgery
Lead Sponsor:
Charles University, Czech Republic
Collaborating Sponsors:
Faculty Hospital Kralovske Vinohrady
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Patients scheduled for elective osteosynthesis of the distal radius will be randomized to receive celecoxib 100 mg orally (PO) at 6 in the morning before surgery and every 12 hours for 2 days thereaft...
Detailed Description
A prospective single-blinded randomized study will be performed in patients of the Orthopaedic Clinic of the 3rd Medical Faculty of Charles University (3LF UK) and the Faculty Hospital Kralovske Vinoh...
Eligibility Criteria
Inclusion
- Patients scheduled for osteosynthesis of distal radius fracture
Exclusion
- Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib
- History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs.
- Patients who have demonstrated allergic-type reactions to sulfonamides.
- Inability to understand the questionnaire
Key Trial Info
Start Date :
February 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05288374
Start Date
February 10 2022
End Date
December 31 2023
Last Update
February 7 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty Hospital Kralovske Vinohrady
Prague, Czechia, 100 00
2
Jiří Málek
Prague, Czechia, 13000